Community Medicine (PSM) · National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A)

Under the National Tuberculosis Elimination Programme (NTEP), which of the following criteria defines a 'treatment failure' in a drug-sensitive TB patient on first-line DOTS?

  • A Sputum smear positive at end of the intensive phase (month 2)
  • B Sputum smear or culture positive at month 5 or later during treatment
  • C Weight loss of more than 5 kg during the continuation phase
  • D Development of adverse drug reactions requiring temporary treatment interruption
Correct answer: B. Sputum smear or culture positive at month 5 or later during treatment

Explanation

Under NTEP (aligned with WHO 2013 revised definitions), treatment failure in a pulmonary TB patient is defined as remaining sputum smear- or culture-positive at month 5 or later during treatment. Positivity at month 2 may indicate slow response and triggers enhanced monitoring but alone does not define failure. Treatment interruption due to adverse effects is managed differently.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs

See all National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs →